Next Investors logo grey

Dyesol gains support from CSIRO for solar cell development

Published 24-OCT-2016 12:12 P.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

After the market closed on Friday, Dyesol (ASX: DYE) announced that it had signed a letter of intent with the Commonwealth Scientific and Industrial Research Organisation (CSIRO) to collaborate in the field of Perovskite Solar Cells (PSC).

To provide some background, PSC technology is a photovoltaic (PV) technology based on applying low-cost materials in a series of ultra-thin layers encapsulated by protective sealants.

While the company’s technologies would appear to have strong end markets, DYE is in the relatively early stages of development and as such should be considered a speculative stock. Investors should not make assumptions regarding potential development outcomes, nor should they use historical trading patterns as a guide to future share price performance. Independent professional financial advice should be sought if considering an investment in this company.

DYE’s technology has lower embodied energy in manufacture, produces stable electrical current, and has a strong competitive advantage in low light conditions relative to incumbent PV technologies. This technology can be directly integrated into the building envelope to achieve highly competitive building integrated photovoltaics (BIPV).

With DYE being a global leader in the development and commercialisation of PSC technology and the CSIRO already substantially invested in the group’s activities as its fourth largest individual shareholder, the establishment of an agreement to work towards a framework of collaboration, cooperation and coordination should be viewed as a positive in terms of an endorsement of the technology, as well as providing the potential to improve and/or fast track this development.

The non-binding letter of intent allows for individual projects to be the subject of specific binding agreements and also establishes a framework for the parties to combine their technical and commercial expertise in seeking to access various government funding sources in the future.

In response to this development, DYE’s Managing Director, Richard Caldwell said, “We believe CSIRO, currently our fourth-largest individual shareholder, is ideally positioned to explore opportunities to improve and enhance technology as we plan and execute the launch of Perovskite Solar Cell PV products for commercialisation for years to come”.

In the last fortnight DYE’s share price has increased from 19 cents to a high of 23 cents, representing an increase of more than 20%. While there was a slight retracement to 21.5 cents towards the end of last week, given this news came after the market closed on Friday, the related upside could be evident today.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.